サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1529860

医療用特殊バッグの市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2024-2030年

Medical Specialty Bags Market Size, Share & Trends Analysis Report By Product (Ostomy Collection Bags, Urinary Collection Bags, Blood Bags, Bile Collection Bags, Sterile Packaging Bags), Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医療用特殊バッグの市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2024-2030年
出版日: 2024年07月25日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医療用特殊バッグ市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、医療用特殊バッグの世界市場規模は2030年に140億6,000万米ドルと推定され、2023年から2030年にかけてCAGR 4.4％で成長すると予測されています。

高齢化人口の割合の増加や尿失禁などの疾患の流行が、今後7年間の市場成長の主な促進要因になると予想されます。

製品提供の費用対効果を改善することで、顧客の注目を集めることを意図した政府の政策やイニシアチブは、予測期間中の需要を促進すると予想されます。製品の魅力を高めるための償還政策の合理化も、予測期間における医療用特殊バッグ市場の成長に大きな役割を果たすと予想されます。

可処分所得の上昇と様々な疾患に関する健康意識の高まりは、アンメット・メディカル・ニーズの増加と相まって、ブラジル、中国、インドなどの新興国における手頃な価格の医療用特殊バッグのイントロダクションと相まって、業界の将来の成長を促進すると予想されます。米国とカナダにおける医療機器に対する高い物品税率は、今後7年間の医療用特殊バッグ市場にとって重要な課題となることが予想されます。

医療用特殊バッグ市場は、製品タイプに基づいて、採尿バッグ、麻酔呼吸バッグ、無菌包装バッグ、血液バッグ、胆汁採取バッグ、死体バッグ、オストミーバッグ、経腸栄養バッグ、静脈内輸液バッグ、持続的外来腹膜透析バッグに大別されます。（CAPD）などがあります。

医療用特殊バッグ市場のレポートハイライト

  • オストミー回収バッグは2013年に最大の製品セグメントとなり、2014年から2020年にかけてCAGR 4.3%で成長し、29億4,000万米ドルに達すると推定されます。一方、胆汁採取バッグは、低侵襲性の腹腔鏡下胆嚢摘出術のニーズの高まりから、2014年から2020年にかけてCAGR 6.5%の急成長が見込まれています。
  • 輸液バッグ市場の収益は2020年までに24億6,990万米ドルに達し、2014年から2020年までのCAGRは5.2%で成長すると推定されます。医療用特殊バッグは、在宅ヘルスケアや手術センターなどのニッチセグメントで構成されています。SurgiCentersのような病院以外の小規模プレーヤーは、需要の増加と顧客の認知度により市場成長を牽引すると予想されます。これらのバッグは病院での手術に使用されます。
  • 北米は、洗練されたヘルスケアインフラの存在、患者の意識レベルの向上、および償還の枠組みにより、2013年の市場で最大のシェアを占めました。これらの要素が、同地域における高い使用率と手術件数の原因となっています。
  • アジア太平洋地域の医療用特殊バッグ市場は、2014年から2020年にかけて6.0%以上のCAGRで最も高い成長が見込まれます。医療知識の向上、ヘルスケアインフラと医療費の改善に加え、予測期間中の急成長が期待される要因のいくつかです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 医療用特殊バッグ市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • 医療用特殊バッグ市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • パイプライン分析

第4章 医療用特殊バッグ市場：治療別推定・動向分析

  • 世界の医療用特殊バッグ市場：製品別ダッシュボード
  • 世界の医療用特殊バッグ市場：製品別変動分析
  • 世界の医療用特殊バッグ市場：製品別収益
  • オストミー採取バッグ
  • 静脈内（IV）輸液バッグ
  • 持続携帯型腹膜透析（CAPD）バッグ
  • 採尿バッグ
  • 滅菌包装バッグ
  • 麻酔呼吸バッグ
  • 死体袋
  • 血液バッグ
  • 浣腸バッグ
  • 経腸栄養バッグ
  • 胆汁採取バッグ
  • 氷袋

第5章 医療用特殊バッグ市場：地域別推定・動向分析

  • 地域別ダッシュボード
  • 市場規模、予測動向分析、2018年から2030年：
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第6章 競合情勢

  • 企業/競合の分類
  • ベンダー情勢
    • 主要販売代理店およびチャネル パートナーのリスト
    • 主要顧客
    • 主要企業の市場シェア分析、2023 年
    • B. Braun SE
    • Baxter
    • Bard
    • Coloplast A/S
    • Convatec Inc.
    • Fresenius Medical Care AG
    • Hollister Incorporated
    • SB-KAWASUMI LABORATORIES, INC.
    • Macopharma
    • Pall Corporation（Danaher）
    • Terumo Corporation
    • Westfield Medical Ltd.
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America medical specialty bags market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 4 U.S. medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 6 Mexico medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe medical specialty bags market, by region, 2018 - 2030 (USD Million)
  • Table 8 Europe medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 9 Germany medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 10 UK medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 11 France medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 12 Italy medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 13 Spain medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 14 Denmark medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 15 Sweden medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 16 Norway medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific medical specialty bags market, by region, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 19 China medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 20 Japan medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 21 India medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 22 South Korea medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 23 Australia medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 24 Thailand medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America medical specialty bags market, by region, 2018 - 2030 (USD Million)
  • Table 26 Latin America medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 27 Brazil medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 29 MEA medical specialty bags market, by region, 2018 - 2030 (USD Million)
  • Table 30 MEA medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 31 South Africa medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE medical specialty bags market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait medical specialty bags market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Medical specialty bags market: market outlook
  • Fig. 14 Medical specialty bags competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Medical specialty bags market driver impact
  • Fig. 18 Medical specialty bags market restraint impact
  • Fig. 19 Medical specialty bags market: Product movement analysis
  • Fig. 20 Medical specialty bags market: Product outlook and key takeaways
  • Fig. 21 Ostomy collection bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Single use market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Multiple use market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Intravenous (IV) fluid bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 PVC market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Non-PVC market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Continuous ambulatory peritoneal dialysis (CAPD) bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Disposable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Reusable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Resuscitation bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Urinary collection bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Sterile packaging bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Anesthesia breathing bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Cadaver (Body) bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Blood bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Enema bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Enteral feeding bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Bile collection bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Ice bags market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Global Medical specialty bags market: Regional movement analysis
  • Fig. 41 Global Medical Specialty Bags market: Regional outlook and key takeaways
  • Fig. 42 Global Medical Specialty Bags market share and leading players
  • Fig. 43 North America, by country
  • Fig. 44 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. key country dynamics
  • Fig. 46 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Canada key country dynamics
  • Fig. 48 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico key country dynamics
  • Fig. 50 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 UK key country dynamics
  • Fig. 53 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Germany key country dynamics
  • Fig. 55 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 France key country dynamics
  • Fig. 57 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Italy key country dynamics
  • Fig. 59 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Spain key country dynamics
  • Fig. 61 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Denmark key country dynamics
  • Fig. 63 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Sweden key country dynamics
  • Fig. 65 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Norway key country dynamics
  • Fig. 67 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 China key country dynamics
  • Fig. 70 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Japan key country dynamics
  • Fig. 72 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 India key country dynamics
  • Fig. 74 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Thailand key country dynamics
  • Fig. 76 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 South Korea key country dynamics
  • Fig. 78 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Australia key country dynamics
  • Fig. 80 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Brazil key country dynamics
  • Fig. 83 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Argentina key country dynamics
  • Fig. 85 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 South Africa key country dynamics
  • Fig. 88 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Saudi Arabia key country dynamics
  • Fig. 90 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 UAE key country dynamics
  • Fig. 92 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Kuwait key country dynamics
  • Fig. 94 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Market share of key market players- medical specialty bags market
目次
Product Code: 978-1-68038-172-6

Medical Specialty Bags Market Growth & Trends:

The global medical specialty bags market size was estimated at USD 14.06 billion in 2030 and is expected to grow at a CAGR of 4.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. Growing percentage of aging population and prevailing diseases such as urinary incontinence is expected to be the key driving factor for market growth over the next seven years.

Government policies and initiatives intended to draw customer attention by improving the cost-effectiveness of product offering is expected to drive demand over the forecast period. Streamlined reimbursement policies to make the product more attractive is also expected to play a major role in the growth of the medical specialty bag market over the forecast period.

Rise in the disposable income and growing health awareness regarding various diseases coupled with increasing unmet medical needs and the introduction of affordable medical specialty bags in emerging economies such as Brazil, China, and India is anticipated to propel the future growth of the industry. High excise tax rates on healthcare devices in theU.S and Canada is expected to serve as a key challenge for the medical specialty bags market over the next seven years.

Based on the type of product, the medical specialty bag market is broadly classified into urinary collection bags, anesthesia breathing bags, sterile packaging bags, blood bags, bile collection bags, cadaver bags, ostomy bags, enteral feeding bags, intravenous fluid bags, and continuous ambulatory peritoneal dialysis bags. (CAPD).

Medical Specialty Bags Market Report Highlights:

  • Ostomy collection bags was the largest product segment in 2013 and is estimated to grow at a CAGR of 4.3% from 2014 to 2020 to reach USD 2.94 billion. Bile collection bags, on the other hand, are expected to grow at a fast pace with a CAGR of 6.5% from 2014 to 2020, on account of the rising need for minimally invasive laparoscopic cholecystectomy procedures.
  • Intravenous (IV) fluid bags market revenue is estimated to reach USD 2,469.9 million by 2020, growing at a CAGR of 5.2% from 2014 to 2020. Medical specialty bags comprise niche segments including home healthcare and SurgiCenters. Small non-hospital players such as SurgiCenters are expected to drive the market growth owing to increasing demand and customer awareness. These bags are used for surgeries in hospitals.
  • North America accounted for the largest share of the market in 2013 owing to the existence of sophisticated healthcare infrastructure, better patient awareness levels, and reimbursement framework. These elements are responsible for high rates of usage and procedure volumes in the region.
  • Asia Pacific medical specialty bags markets expected to grow at the highest CAGR of over 6.0% from 2014 to 2020. Improved medical knowledge, in addition to improving healthcare infrastructure and disbursements, are some of the factors expected to account for its rapid growth over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Medical Specialty Bags Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Medical Specialty Bags Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pipeline Analysis

Chapter 4. Medical Specialty Bags Market: Treatment Estimates & Trend Analysis

  • 4.1. Global Medical Specialty Bags Market: Product Dashboard
  • 4.2. Global Medical Specialty Bags Market: Product Movement Analysis
  • 4.3. Global Medical Specialty Bags Market by Product, Revenue
  • 4.4. Ostomy Collection Bags
    • 4.4.1. Ostomy Collection Bags market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Single use
      • 4.4.2.1. Single use market estimates and segment forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Multiple use
      • 4.4.3.1. Multiple use market estimates and segment forecasts 2018 to 2030 (USD Million)
  • 4.5. Intravenous (IV) Fluid Bags
    • 4.5.1. Intravenous (IV) fluid bags market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. PVC
      • 4.5.2.1. PVC market estimates and segment forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Non-PVC
      • 4.5.3.1. Non-PVC market estimates and segment forecasts 2018 to 2030 (USD Million)
  • 4.6. Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags
    • 4.6.1. Continuous ambulatory peritoneal dialysis (CAPD) Bags market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Bags
      • 4.6.2.1. Bags market estimates and segment forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Disposable
      • 4.6.3.1. Disposable market estimates and segment forecasts 2018 to 2030 (USD Million)
    • 4.6.4. Reusable
      • 4.6.4.1. Reusable market estimates and segment forecasts 2018 to 2030 (USD Million)
  • 4.7. Urinary Collection Bags
    • 4.7.1. Urinary collection bags market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Sterile Packaging Bags
    • 4.8.1. Sterile packaging bags market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Anesthesia Breathing Bags
    • 4.9.1. Anesthesia breathing bags market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.10. Cadaver (Body) Bags
    • 4.10.1. Cadaver (Body) bags market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.11. Blood Bags
    • 4.11.1. Blood bags market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.12. Enema Bags
    • 4.12.1. Enema bags market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.13. Enteral Feeding Bags
    • 4.13.1. Enteral feeding bags market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.14. Bile Collection Bags
    • 4.14.1. Bile collection bags market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.15. Ice Bags
    • 4.15.1. Ice Bags market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Medical Specialty Bags Market: Regional Estimates & Trend Analysis by Product

  • 5.1. Regional Dashboard
  • 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.3. North America
    • 5.3.1. U.S.
      • 5.3.1.1. Key country dynamics
      • 5.3.1.2. Regulatory framework/ reimbursement structure
      • 5.3.1.3. Competitive scenario
      • 5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Canada
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Mexico
      • 5.3.3.1. Key country dynamics
      • 5.3.3.2. Regulatory framework/ reimbursement structure
      • 5.3.3.3. Competitive scenario
      • 5.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. France
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Norway
      • 5.4.6.1. Key country dynamics
      • 5.4.6.2. Regulatory framework/ reimbursement structure
      • 5.4.6.3. Competitive scenario
      • 5.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.7. Sweden
      • 5.4.7.1. Key country dynamics
      • 5.4.7.2. Regulatory framework/ reimbursement structure
      • 5.4.7.3. Competitive scenario
      • 5.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Key country dynamics
      • 5.4.8.2. Regulatory framework/ reimbursement structure
      • 5.4.8.3. Competitive scenario
      • 5.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. India
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. South Korea
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Argentina
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. MEA
    • 5.7.1. South Africa
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Saudi Arabia
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Vendor Landscape
    • 6.2.1. List of key distributors and channel partners
    • 6.2.2. Key customers
    • 6.2.3. Key company market share analysis, 2023
    • 6.2.4. B. Braun SE
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Baxter
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Bard
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Coloplast A/S
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Convatec Inc.
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Fresenius Medical Care AG
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Hollister Incorporated
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
    • 6.2.11. SB-KAWASUMI LABORATORIES, INC.
      • 6.2.11.1. Company overview
      • 6.2.11.2. Financial performance
      • 6.2.11.3. Product benchmarking
      • 6.2.11.4. Strategic initiatives
    • 6.2.12. Macopharma
      • 6.2.12.1. Company overview
      • 6.2.12.2. Financial performance
      • 6.2.12.3. Product benchmarking
      • 6.2.12.4. Strategic initiatives
    • 6.2.13. Pall Corporation (Danaher)
      • 6.2.13.1. Company overview
      • 6.2.13.2. Financial performance
      • 6.2.13.3. Product benchmarking
      • 6.2.13.4. Strategic initiatives
    • 6.2.14. Terumo Corporation
      • 6.2.14.1. Company overview
      • 6.2.14.2. Financial performance
      • 6.2.14.3. Product benchmarking
      • 6.2.14.4. Strategic initiatives
    • 6.2.15. Westfield Medical Ltd.
      • 6.2.15.1. Company overview
      • 6.2.15.2. Financial performance
      • 6.2.15.3. Product benchmarking
      • 6.2.15.4. Strategic initiatives